文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

miR-30a 通过靶向 SOCS3 增加 B 细胞淋巴瘤小鼠中 MDSC 的分化和免疫抑制功能。

MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.

机构信息

The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, China.

Jiangsu Key Laboratory of Molecular Medicine, Nanjing, China.

出版信息

FEBS J. 2017 Aug;284(15):2410-2424. doi: 10.1111/febs.14133. Epub 2017 Jul 21.


DOI:10.1111/febs.14133
PMID:28605567
Abstract

Myeloid-derived suppressor cells (MDSCs), including granulocytic (G)-MDSCs and monocytic (M)-MDSCs, play a critical role in tumor-induced T cell tolerance. MDSC immunosuppressive function and differentiation are significantly promoted in patients and B-cell lymphoma model mice. However, the mechanisms regulating these processes remain largely unclear. In the present study, we observed increased microRNA (miR)-30a expression both in G-MDSCs and in M-MDSCs from B cell lymphoma model mice. After transfection with miR-30a mimics, the differentiation and suppressive capacities of MDSCs were significantly increased via up-regulation of arginase-1. Moreover, we showed that the 3'-UTR of suppressor of cytokine signaling 3 (SOCS3) mRNA is a direct target of miR-30a. Decreased SOCS3 expression and activated Janus kinase-signal transducer and activator of transcription 3 signaling promote MDSC differentiation and suppressive activities. These findings provide new insights into the molecular mechanisms underlying MDSC expansion and function during B cell lymphoma development.

摘要

髓系来源的抑制性细胞(MDSCs),包括粒细胞(G)-MDSCs 和单核细胞(M)-MDSCs,在肿瘤诱导的 T 细胞耐受中发挥关键作用。在患者和 B 细胞淋巴瘤模型小鼠中,MDSC 的免疫抑制功能和分化显著增强。然而,调节这些过程的机制在很大程度上仍不清楚。在本研究中,我们观察到 B 细胞淋巴瘤模型小鼠的 G-MDSCs 和 M-MDSCs 中 miR-30a 的表达增加。转染 miR-30a 模拟物后,通过上调精氨酸酶 1,MDSC 的分化和抑制能力显著增加。此外,我们表明 SOCS3 mRNA 的 3'-UTR 是 miR-30a 的直接靶标。SOCS3 表达降低和激活的 Janus 激酶-信号转导和转录激活因子 3 信号促进 MDSC 的分化和抑制活性。这些发现为 B 细胞淋巴瘤发展过程中 MDSC 扩增和功能的分子机制提供了新的见解。

相似文献

[1]
MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma.

FEBS J. 2017-7-21

[2]
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Acta Neuropathol. 2017-1

[3]
The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.

Cell Death Dis. 2017-3-23

[4]
Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.

Oncogene. 2018-5-1

[5]
HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3-miR124 Axis.

Cells. 2020-12-18

[6]
Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.

Int J Mol Sci. 2018-3-15

[7]
Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.

J Immunol. 2020-6-15

[8]
MicroRNA-150 inhibits myeloid-derived suppressor cells proliferation and function through negative regulation of ARG-1 in sepsis.

Life Sci. 2021-8-1

[9]
MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.

Eur Rev Med Pharmacol Sci. 2017-11

[10]
Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing mice.

Int Immunopharmacol. 2017-6

引用本文的文献

[1]
miRNAs and T cell-mediated Immune Response in Disease.

Yale J Biol Med. 2025-6-30

[2]
A silence catalyst: CCL5-mediated intercellular communication in cancer.

Arch Toxicol. 2025-4-1

[3]
The epigenetic hallmarks of immune cells in cancer.

Mol Cancer. 2025-3-5

[4]
Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma.

Front Med (Lausanne). 2025-1-29

[5]
Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment.

Explor Target Antitumor Ther. 2024

[6]
MiR-210 promotes bone formation in ovariectomized rats by regulating osteogenic/adipogenic differentiation of bone marrow mesenchymal stem cells through downregulation of EPHA2.

J Orthop Surg Res. 2023-10-30

[7]
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies.

Front Cell Dev Biol. 2023-4-5

[8]
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies.

Biomark Res. 2023-3-29

[9]
Noncoding RNAs Controlling Oxidative Stress in Cancer.

Cancers (Basel). 2023-2-10

[10]
Insights into the tumor microenvironment of B cell lymphoma.

J Exp Clin Cancer Res. 2022-12-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索